Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content
Focused on muscle and
positioned for growth

SEC Filing

SEC Filing Details

Document Details

Form
Filing Date
Nov 3, 2022
Document Date
Sep 30, 2022
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Dyne Therapeutics, Inc.
Issuer
DYNE THERAPEUTICS, INC.